Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$31.66 - $38.9 $7,281 - $8,947
-230 Reduced 3.33%
6,677 $225,000
Q1 2022

May 05, 2022

SELL
$30.45 - $39.36 $6,577 - $8,501
-216 Reduced 3.03%
6,907 $241,000
Q4 2021

Feb 09, 2022

SELL
$28.67 - $37.13 $7,167 - $9,282
-250 Reduced 3.39%
7,123 $217,000
Q3 2021

Nov 05, 2021

SELL
$28.63 - $35.64 $28,000 - $34,855
-978 Reduced 11.71%
7,373 $242,000
Q2 2021

Aug 03, 2021

BUY
$28.45 - $38.0 $237,585 - $317,338
8,351 New
8,351 $253,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.91B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track 1 St Source Bank Portfolio

Follow 1 St Source Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

News

Stay updated on 1 St Source Bank with notifications on news.